APLLTD:NSE Alembic Pharmaceuticals Limited

INR 1,076.95 -6.50 -0.599935
Icon

Alembic Pharmaceuticals Limited (APLLTD:NSE) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSE
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

INR 1,076.95

-6.50 (-0.60)%

INR 209.54B

0.67M

INR 987.25(-8.33%)

INR 640.00 (-40.57%)

Icon

APLLTD:NSE

Alembic Pharmaceuticals Limited (INR)
COMMON STOCK | NSE
INR 1,076.95
0.00 0
Take a Tour
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

INR 209.54B

INR 640.00 (-40.57%)

INR 1,076.95

Alembic Pharmaceuticals Limited (APLLTD:NSE) Stock Forecast

INR 987.25
(-8.33%)

Based on the Alembic Pharmaceuticals Limited stock forecast from 2 analysts, the average analyst target price for Alembic Pharmaceuticals Limited is INR 987.25 over the next 12 months. Alembic Pharmaceuticals Limited’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Alembic Pharmaceuticals Limited is Neutral, which is based on 5 positive signals and 6 negative signals. At the last closing, Alembic Pharmaceuticals Limited’s stock price was INR 1,076.95. Alembic Pharmaceuticals Limited’s stock price has changed by +7.78% over the past week, +24.07% over the past month and +63.37% over the last year.

No recent analyst target price found for Alembic Pharmaceuticals Limited
No recent average analyst rating found for Alembic Pharmaceuticals Limited

Company Overview Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrol...Read More

Alembic Road, Vadodara, India, 390003

14,858

March

INR

India

Adjusted Closing Price for Alembic Pharmaceuticals Limited (APLLTD:NSE)

Loading...

Unadjusted Closing Price for Alembic Pharmaceuticals Limited (APLLTD:NSE)

Loading...

Share Trading Volume for Alembic Pharmaceuticals Limited Shares

Loading...

Compare Performance of Alembic Pharmaceuticals Limited Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for APLLTD:NSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Alembic Pharmaceuticals Limited (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SUNPHARMA:NSE
Sun Pharmaceutical Industries .. +14.95 (+0.95%) INR3,781.34B 39.44 26.65

ETFs Containing APLLTD

Symbol Name APLLTD's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Alembic Pharmaceuticals Limited (APLLTD:NSE) Stock

Based on ratings from 2 analysts Alembic Pharmaceuticals Limited's stock is Hold . Stock Target Advisor's fundamental analysis is Neutral. The stock has buy, sell and 4 hold ratings.

APLLTD:NSE stock's dividend yield is 1.02%. Our analysis grades APLLTD:NSE stock's dividend yield at B+. This means that APLLTD:NSE stock's dividend yield is above 88% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange. Based on this APLLTD:NSE may be a good dividend stock for its sector.

Based on targets from 2 analysts, the average taret price for APLLTD:NSE is INR 987.25 over the next 12 months. The maximum analyst target price is INR 1023 while the minimum anlayst target price is INR 970.

APLLTD:NSE stock's Price/Earning ratio is 33.80. Our analysis grades APLLTD:NSE stock's Price / Earning ratio at F. This means that APLLTD:NSE stock's Price/Earning ratio is above 42.00000000000001% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange. Based on this APLLTD:NSE may be fairly valued for its sector

The last closing price of APLLTD:NSE's stock was INR 1,076.95.

The most recent market capitalization for APLLTD:NSE is INR 209.54B.

Based on targets from 2 analysts, the average taret price for APLLTD:NSE is projected at INR 987.25 over the next 12 months. This means that APLLTD:NSE's stock price may go down by -8.33% over the next 12 months.

We can't find any ETFs which contains Alembic Pharmaceuticals Limited's stock.

As per our most recent records Alembic Pharmaceuticals Limited has 14,858 Employees.

Alembic Pharmaceuticals Limited's registered address is Alembic Road, Vadodara, India, 390003. You can get more information about it from Alembic Pharmaceuticals Limited's website at https://alembicpharmaceuticals.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...